Anticoagulation associated intracerebral haemorrhage trends, treatment and outcomes in a metropolitan cohort: analysed by availability of specific versus non-specific reversal agents. [PDF]
BMJ Neurol OpenEl-Masri S +12 more
europepmc +1 more source
Inhibition of adenosine kinase alleviates hypertrophic cardiomyopathy by ameliorating coronary microvascular dysfunction. [PDF]
ESC Heart FailWan F +7 more
europepmc +1 more source
Intravenous thrombolysis for acute cerebral embolism during atrial fibrillation ablation: a case report and systematic review with meta-analysis. [PDF]
Front Cardiovasc MedCai B +5 more
europepmc +1 more source
The novel anticoagulant dabigatran versus enoxaparin for thromboprophylaxis following total hip replacement: a meta-analysis. [PDF]
BMC Cardiovasc DisordHuang J, Ye J.
europepmc +1 more source
Dabigatran Reversal with Idarucizumab
New England Journal of Medicine, 2017 Pollack, Charles V. +2 more
openaire +6 more sources
Dabigatran outperforms warfarin in elderly patients with atrial fibrillation and stable coronary artery disease: reduced risks of bleeding and cardiovascular events. [PDF]
Am J Transl ResSong L, Li N, Wang Z, Yu J, Qin J.
europepmc +1 more source
Assessment of the Drug-Drug Interaction Potential of Lotiglipron (PF-07081532) with Midazolam, Omeprazole, Dabigatran, Rosuvastatin, and the Oral Contraceptives Levonorgestrel and Ethinyl Estradiol. [PDF]
J Clin PharmacolCronenberger C +11 more
europepmc +1 more source
Dabigatran-induced acute hepatitis in a patient with atrial fibrillation: a rare case report. [PDF]
Eur Heart J Case RepHsu CW, Chang HR, Wu SC.
europepmc +1 more source
Bothrops jararaca snake venom: A reappraisal of its coagulant activity in humans, mice, and rats. [PDF]
PLoS Negl Trop DisTorres AV +7 more
europepmc +1 more source